ArticleThe American journal of tropical medicine and hygiene2013
The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.
Article in The American journal of tropical medicine and hygiene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Financial hardship among patients suffering from neglected tropical diseases: A systematic review and meta-analysis of global literature.PLoS neglected tropical diseases · 2024Pooled it
- Vector-Borne and Zoonotic Diseases in the Eastern Mediterranean Region: A Systematic Review.Journal of epidemiology and global health · 2023Pooled it
- The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review.PloS one · 2019Pooled it
- Efficacy and cost-effectiveness of outdoor residual spraying with α-cypermethrin, pirimiphos-methyl, and deltamethrin against sand flies: a pragmatic cluster randomised controlled field trial in Uganda.Tropical medicine and health · 2026Article
- Leishmaniases: Strategies in treatment development.Parasite (Paris, France) · 2025Review
- The economic burden of visceral leishmaniasis and barriers to accessing healthcare in Tigray, North Ethiopia: A field based study.PLoS neglected tropical diseases · 2024Article
- Micro and nanotechnologies: The little formulations that could.Bioengineering & translational medicine · 2023Review
- Review of the neglected tropical diseases programme implementation during 2012-2019 in the WHO-Eastern Mediterranean Region.PLoS neglected tropical diseases · 2022Review
- Prevalence of human leishmaniasis in Sudan: A systematic review and meta-analysis.World journal of methodology · 2022Article
- Overcoming roadblocks in the development of vaccines for leishmaniasis.Expert review of vaccines · 2021Review
- Leishmaniasis Beyond East Africa.Frontiers in veterinary science · 2021Review
- Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review.Research and reports in tropical medicine · 2021Review
- Outdoor Residual Insecticide Spraying (ODRS), a New Approach for the Control of the Exophilic Vectors of Human Visceral Leishmaniasis: Phlebotomus orientalis in East Africa.PLoS neglected tropical diseases · 2020Article
- Article
- Leishmaniasis patients' pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach.BMC international health and human rights · 2019Article
- "The American journal of tropical medicine and hygiene · 2018Article
- Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease.PLoS neglected tropical diseases · 2018Article
- The monetary value of human lives lost due to neglected tropical diseases in Africa.Infectious diseases of poverty · 2017Article
- Cost-effectiveness of diagnostic-therapeutic strategies for paediatric visceral leishmaniasis in Morocco.BMJ global health · 2017Article
- Nanostructured delivery systems with improved leishmanicidal activity: a critical review.International journal of nanomedicine · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated and is endemic in eastern Sudan. We estimated the direct and indirect costs of treatment of VL from the perspective of the provider and the household at three public hospitals in Gedaref State. The median total cost for one VL episode was estimated to be US$450. Despite the free provision of VL drugs at public hospitals, households bore 53% of the total cost of VL with one episode of VL representing 40% of the annual household income. More than 75% of households incurred catastrophic out-of-pocket expenditures. The length of treatment of 30 days led to important costs for both health providers and households. Alternative treatment regimens that reduce the duration of treatment are urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.